The Future of Vaccine Compensation: Moving Toward a Fairer System
The conversation around vaccine injury is shifting from individual tragedies to a systemic demand for legislative reform. For years, the Vaccine Damage Payment (VDP) scheme has operated as a one-off payment of £120,000 for those severely disabled or bereaved due to certain vaccinations.
However, evidence from recent pandemic probes suggests this model is outdated. Experts and bereaved families, such as Sheila Ward from Newcastle-under-Lyme, are pushing for a system that reflects modern economic realities and the actual cost of long-term care.
Inflation-Linked Payments and Financial Sustainability
One of the most significant trends is the push for inflation-linked payouts. Baroness Heather Hallett, chairwoman of the pandemic probe, has highlighted that the current payment is “too low” and requires “urgent reform.”
Proposed changes suggest that if payments were adjusted for inflation, the minimum amount would now exceed £200,000. This shift would move compensation from a static figure to a dynamic one, ensuring that the support provided to the vaccine-injured does not erode over time.
Redefining the “Fairer System” for Claims
Beyond the amount of money, there is a growing movement to change how payments are determined. Legal representatives, including those from Leigh Day and Hudgell Solicitors, have pointed out that the current form of the VDP scheme fails to provide timely or adequate support.
The trend is moving toward a “fairer system” that acknowledges the life-changing impact of rare side effects, such as Thrombosis with Thrombocytopenia Syndrome (TTS), without placing an undue evidentiary burden on the bereaved.
Enhancing Global Vaccine Safety Monitoring
While the AstraZeneca vaccine (Vaxzevria) was hailed as a “triumph for British science” and estimated to have saved 6.3 million lives globally, the “rare cases” of serious injury have sparked a demand for better surveillance.
Future safety protocols are expected to focus on more integrated data sharing. Baroness Hallett has specifically called for regulatory bodies to have direct access to healthcare records to improve safety monitoring for latest vaccines and therapeutics.
Balancing Public Health Success with Individual Harm
The medical community faces the ongoing challenge of communicating the balance between massive public health gains and rare, severe risks. In England and Scotland alone, vaccines are estimated to have saved 475,000 lives by March 2023.
The future trend in medical ethics is a more transparent acknowledgment of these “rare” events. As seen in the case of Stephen Ward, whose death was ruled a result of cerebral venous sinus thrombosis caused by the AstraZeneca vaccine, there is a growing consensus that these individual losses are “of no less importance” than the overall scale of the vaccination programme.
The Role of Legal Precedents in Changing Law
We are seeing a rise in collective legal action to force government change. Groups of claimants, such as the 48 individuals represented by Sarah Moore of Leigh Day, are using their shared experiences to lobby for legislative updates.
This trend suggests that future changes to medical compensation will likely be driven by organized legal challenges and the public testimony of bereaved families rather than voluntary government updates.
Frequently Asked Questions
It is a government scheme that provides a one-off payment, currently £120,000, to individuals who become severely disabled or die as a result of certain vaccinations.
What was the cause of Stephen Ward’s death?
An inquest ruled that Stephen Ward died as a result of cerebral venous sinus thrombosis with intra-cranial haemorrhages, caused by thrombosis with thrombocytopenia syndrome (TTS), which was triggered by the AstraZeneca Covid-19 vaccine.
Why is the VDP scheme being criticized?
Critics, including Baroness Heather Hallett and members of Vibuk, argue that the payment is too low, has not been updated since 2007, and the system for determining payment is not fair or sufficiently supportive.
Was the AstraZeneca vaccine withdrawn?
Yes, the AstraZeneca Covid-19 jab, also known as Vaxzevria, was withdrawn from the market in May 2024.
Join the Conversation: Do you believe vaccine compensation schemes should be linked to inflation? Share your thoughts in the comments below or subscribe to our newsletter for more updates on healthcare legislation and patient rights.
Keep reading
